The Center for Computational Molecular Biology (CCMB) at Brown is a world-class center for research and scholarship in this new discipline. The extraordinary progress of molecular biology in the last several decades has yielded an enhanced understanding of biological processes, while the growth of high-dimensional data generated by genomic and proteomic technologies has brought an entirely new data-driven paradigm to the life sciences. The interdisciplinary interaction of biology and computational and mathematical sciences has already contributed to this understanding, and has led to the recognition of Computational Molecular Biology as a cutting-edge and rapidly-expanding discipline.
The center concentrates its efforts on a number of fundamental biological themes: algorithmic methods and statistical inference in genomics, comparative genomics and evolution, gene regulatory networks, regulatory genomics, mathematical models of genetic variation, genome-wide association studies, and cancer genomics.
This doctoral program is jointly administered by four academic units: Applied Mathematics, Computer Science, Ecology and Evolutionary Biology, and Molecular Biology, Cell Biology, and Biochemistry. The Ph.D. degree will be conferred by one of the participating departments and four corresponding tracks have been defined with discipline-specific course requirements. Students must specify the track for which they wish to be considered in their application.
Additional resources: CCMB computing resources include a set of multi-processor compute clusters and data storage servers with 392 processors. The CCMB Cluster is the largest dedicated computing system on campus for computational biology and bioinformatics applications.
Six graduate-level courses, two eight-week laboratory rotations, preliminary research presentation, dissertation, oral defense
Admission requirements: In the personal statement, please state the preferred degree or track you intend to pursue.
GRE General: Required
GRE Subject: Not required
Application deadline: January 3